May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news ...
J&J will buy Momenta Pharmaceuticals for roughly $6.5 billion in cash, paving the way for its Janssen unit to expand its efforts into autoimmune disease treatments. J&J will pay $52.50 for each ...
Pharmaceutical giant Johnson & Johnson is set to pay $6.475 billion to settle lawsuits alleging its talc-based products, often associated with health concerns, caused cancer. This unprecedented ...
Johnson and Johnson reiterated in its statement on Wednesday, May 1, that “none of the talc-related claims against it have merit” getty Stock image of baby powder Johnson & Johnson has offered to pay ...
Benzinga - by Vandana Singh, Benzinga Editor. Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ...
El gigante farmacéutico estadounidense Johnson & Johnson presentó este miércoles un plan destinado a cerrar las querellas civiles en el caso del talco señalado como cancerígeno, y para eso ...
It is the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the state. Johnson & Johnson must pay US$8 ...
Johnson & Johnson is ordered to pay a $300 million punitive award to a woman who said she contracted cancer through the use of the company's talc-based products. Johnson & Johnson is ordered to ...
El Tribunal Supremo de Estados Unidos se negó el martes a estudiar un recurso de la empresa farmacéutica estadounidense Johnson & Johnson, confirmando así su condena a pagar 2.100 millones de ...
Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a strong pharmaceutical backbone that has emerged over the ...
Johnson & Johnson said it would acquire Proteologix for $850 million as it looks to gain access to the privately held company’s experimental atopic dermatitis treatments. Proteologix’s ...